Klemens Budde
Klemens Budde is an expert in Surgery at Charité - University Medicine Berlin (Germany). As of October 2026, ScienceLeadR ranks Klemens Budde in the top 1% of experts worldwide for Kidney Transplantation and Renal Insufficiency. Klemens Budde has authored 889 publications, the most recent in 2026, and is an investigator in 48 clinical trials, 6 of them ongoing. SLR score: 3,104 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Transplantation - Nephrology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1995 - 2026
Number : 889
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Real-world deployment and longitudinal evaluation of a human-in-the-loop telemedicine communication support system. PMID 42871328 — suggestion, communication, workflow, telemedicine, nephrology | Front Digit Health | 2026 | 0 |
| NK cell missing self in microvascular inflammation with and without donor-specific antibodies. PMID 42841624 — cells, absenteeism, incidence, antibodies, killer cells, natural, biopsy, polymorphism, genetic, kidney transplantation | Nephrol Dial Transplant | 2026 | 0 |
| Belatacept: Better Outcomes, no Cancer Signal, but Limited Global Access. PMID 42715289 — neoplasms, transplantation | Transplantation | 2026 | 0 |
| Beyond the acceptance decision: integrating genetic findings into lifelong living donor care. PMID 42625726 — registries, genetic testing, kidney transplantation, transplantation | Transpl Int | 2026 | 0 |
| Germany's Move Toward Kidney Paired Exchange and Nondirected Donation: Governance Lessons From Abroad. PMID 42598480 — kidney | Kidney Int Rep | 2026 | 0 |
Clinical Studies 48
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 5
Ongoing Clinical Trials
6 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Phase 3 Study of Ravulizumab versus Placebo in Adult Participants at High Risk of DGF after Kidney Transplantation (AWAKE) 2024-517568-48-00 — safety, kidney, delayed graft function, transplants, kidney transplantation, transplantation | Phase 3 | Recruiting | 2025 |
| Multicentre open label randomised two arm parallel group superiority trial to assess bioavailability and practicability of two once daily tacrolimus formulations Envarsus compared with Advagraf administered in kidney transplant recipients 2023-503531-18-00 — graft rejection, biological availability, kidney, tacrolimus, transplants, allografts | Phase 4 | Active not recruiting | 2024 |
| Felzartamab in late ABMR 2024-511764-86-00 | Phase 2 | Recruiting | 2021 |
| A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation NCT07219043 — graft rejection, safety, antibodies, pharmaceutical preparations, kidney, biopsy, transplants, therapeutics | Phase 2 | Recruiting | 2026 |
| BESTOW EXTENSION A Phase 2 Multicenter Open Label Extension Study to Evaluate the Long Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients 2023-503337-21-00 — safety, kidney, transplants, therapeutics, allografts | Phase 2 | Active not recruiting | 2025 |
LeadR Networks
Main global connection map